2016
DOI: 10.1089/jwh.2015.5576
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Diseases and Use of Contraception Among Women at Risk of Unintended Pregnancy

Abstract: Background Women with chronic diseases are at increased risk of having unintended pregnancies. Little is known whether chronic diseases are associated with increased likelihood of effective/highly effective contraceptive use. Methods We analyzed 2008–2010 Florida Behavioral Risk Factor Surveillance System data for women aged 18–44 years who were at risk of unintended pregnancy. Multivariable Poisson regression estimated adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) for contraceptive us… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
25
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(29 citation statements)
references
References 22 publications
3
25
1
Order By: Relevance
“…Although we focused exclusively on young women and included the ability to examine both hormonal and non-hormonal contraceptive methods, we found self-reported hormonal-based contraceptive use among women with chronic disease to be substantially higher than that reported by DeNoble et al [12]. Further, while our prevalence of contraceptive use among women with chronic disease was similar to that reported in a 2016 cross-sectional U.S. study, they found that the use of effective and highly effective contraception was lowest among women aged 18-24 years (<45%) with highly effective contraceptive use driven largely by sterilisation (even for young women) [13]. In contrast, high e cacy contraceptive use in our study was attributed to the use of hormonal LARC.…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…Although we focused exclusively on young women and included the ability to examine both hormonal and non-hormonal contraceptive methods, we found self-reported hormonal-based contraceptive use among women with chronic disease to be substantially higher than that reported by DeNoble et al [12]. Further, while our prevalence of contraceptive use among women with chronic disease was similar to that reported in a 2016 cross-sectional U.S. study, they found that the use of effective and highly effective contraception was lowest among women aged 18-24 years (<45%) with highly effective contraceptive use driven largely by sterilisation (even for young women) [13]. In contrast, high e cacy contraceptive use in our study was attributed to the use of hormonal LARC.…”
Section: Discussionsupporting
confidence: 81%
“…More recently, cross-sectional analysis of population-level data in the U.S. found substantially higher rates of contraceptive use among women of reproductive age with diabetes, cardiovascular disease, or asthma (87%) and when focused on contraceptive e cacy, contraceptive use differed by chronic disease type. Importantly, women with diabetes and cardiovascular disease were more likely to be users of less effective methods than women without chronic disease [13].…”
Section: Introductionmentioning
confidence: 99%
“…These data are similar to those found in other studies showing that reproductive health is often omitted from healthcare transition planning 20 In general, women with chronic diseases are less likely to use contraception, despite the risks of unintended pregnancy. 21,22 One barrier to universal metabolic counseling on contraception is the lack of systematic resources. In the IMD literature, most recommendations are provided on an ad hoc, case report basis.…”
Section: Discussionmentioning
confidence: 99%
“…9 Other studies showed that women with diabetes are also more likely to use less effective forms of contraception and have lower rates of contraceptive use postpartum. 10,11 However, there still exists gaps in our knowledge of the frequency of preconception and contraceptive counseling and LARC uptake specifically for patients with type I diabetes. In addition, there are currently no data or research investigating how frequency of contraceptive counseling and LARC use differs based on diabetes disease severity or what specialty of health care provider is seeing the patient.…”
Section: Introductionmentioning
confidence: 99%
“… 9 Other studies showed that women with diabetes are also more likely to use less effective forms of contraception and have lower rates of contraceptive use postpartum. 10 , 11 …”
Section: Introductionmentioning
confidence: 99%